Cuba advances cancer vaccine development amid U.S. sanctions
Translated from Spanish, summarized and contextualized by DistantNews.
At a glance
- Cuba is developing a potential cancer vaccine, HeberSavax, despite U.S. sanctions.
- The vaccine is described as unique and promising for treating various cancers.
- Cuban officials emphasize the development as a triumph of science and sovereignty against U.S. economic pressure.
Cuba is advancing the development of a novel therapeutic cancer vaccine candidate, known as HeberSavax, demonstrating scientific progress even amidst stringent U.S. sanctions. Foreign Minister Bruno Rodrรญguez Parrilla highlighted on X that the vaccine shows promise for treating different types of cancer.
Rodrรญguez Parrilla stated that despite the "suffocating policy and economic war" imposed by the United States, which severely restricts the import of essential supplies, particularly for healthcare, Cuban science continues to innovate. He presented HeberSavax as an example of products that enhance well-being and national sovereignty, noting its unique status globally.
the science cubana continues designing and creating products that nos brindan more bienestar and sovereignty
The vaccine holds significant potential for treating multiple forms of cancer. Rodrรญguez Parrilla asserted that "preserving the right to life is the primary task of the State and Government of Cuba." He added, "Faced with the criminal imperialist policy, here we respond with more determination, resistance, creation, and independence."
preserving the right to life is the primary task of the State and Government of Cuba. Faced with the criminal imperialist policy, here we respond with more determination, resistance, creation, and independence
During a May meeting focused on health issues, Dr. Yanelys Morera Diaz, the lead scientist for the HeberSavax project at Havana's Center for Genetic Engineering and Biotechnology (CIGB), described the therapy as "very safe." She confirmed that the research has progressed through all stages, from initial animal studies to Phase II clinical trials targeting specific locations. Adverse effects observed have been minimal and manageable, allowing the vaccine candidate to be combined with conventional therapies without increasing toxicity.
While still in the research phase, patients participating in clinical trials have reported significant positive effects on their quality of life, according to Dr. Morera Diaz. The development of HeberSavax is framed by Cuban officials as a testament to the nation's resilience and commitment to scientific advancement in the face of external pressures.
a type of therapy that is very safe
Originally published by Granma in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.